Context and objective: The prevalence of liver pathologies has been increasing since the advent of more sophisticated medical imaging methods. Our objective was to describe the CT aspects of liver pathologies observed at CIMR. Methods: This was a descriptive observational study of a retrospective series of 304 cases received at the ROCHER Medical Imaging Center (CIMR) in Kinshasa over a period of 24 months, going from January 2020 to January 2022. The parameters of the interests were sociodemographic, clinical and CT. Results: The incidence of liver disease in this population was therefore 12.8%. The average age was 55.42 ± 16.6 years with the range from 35 to 71 years with a F/M sex ratio of 1.3. The characterization of a mass and the exploration of cholestasis represented the most frequent indications. Solid lesions classified as LI-RADS 5 were found the most (26.1%) and LI-RADS 4 (18%). Biliary cysts were the fluid masses most frequently found in (42.9%) followed by abscesses (37.1%). Female subjects were in the majority in solid (54%) and fluid (65.7%) masses with a statistically significant difference compared to male subjects (p = 0.001). Furthermore, the average age of patients with solid masses (57.2 ± 9.9 years) was statistically higher (p = 0.031) compared to the average age of patients with fluid masses (49.7 ± 9.8 years). Bile duct dilatations were accompanied by detectable masses in 88.2%. The same observation was made in the dilatations of VBIH and normal VBP (n = 35) which were accompanied by tumor lesion in 88.6%. Out of a total of 146 cases of diffuse pathologies observed, cirrhosis was found in 85% compared to 15% of cases for fatty liver. Conclusion: CT makes it possible to highlight liver pathologies in a certain frequency. Solid lesions classified LI-RADS 5 and LI-RADS 4 are the most common (18%). While biliary cysts and abscesses are the most commonly found fluid masses.
References
[1]
Alhyari, A., Görg, C., Alakhras, R., Dietrich, C. F., Trenker, C., & Safa Zadeh, E. (2022). HCC or Something Else? Frequency of Various Benign and Malignant Etiologies in Cirrhotic Patients with Newly Detected Focal Liver Lesions in Relation to Different Clinical and Sonographic Parameters. Diagnostics, 12, Article No. 2079. https://doi.org/10.3390/diagnostics12092079
[2]
Bossali, F., Koumou Okandze, L., Katende, S., & Thouassa, A. (2011). Seroprevalence of Hepatitis B in Patients with Cirrhosis and Patients with Hepatocellular Carcinoma in PointeNoire from 2005 to 2008. Journal Africain d'Hépato-Gastroentérologie, 5, 2-5. https://doi.org/10.1007/s12157-010-0224-4
[3]
Casellas, F., Herrera-de Guise, C., Robles, V., Navarro, E., & Borruel, N. (2017). Patient Preferences for Inflammatory Bowel Disease Treatment Objectives. Digestive and Liver Disease, 49, 152-156. https://doi.org/10.1016/j.dld.2016.09.009
[4]
Choi, J. Y., Cho, H. C., Sun, M. et al. (2013) Indeterminate Observations (Liver Imaging Reporting and Data System Category 3) on MRI in the Cirrhoticliver: Fate and Clinical Implications. American Journal of Roentgenology, 201, 993-1001. https://doi.org/10.2214/AJR.12.10007
[5]
Dhaliwal, A., McKeown, J., & Bhat, I. (2021). Malignant Melanoma: A Rare Cause of Obstructive Jaundice. Journal of Gastrointestinal Surgery, 25, 1076-1077. https://doi.org/10.1007/s11605-020-04805-1
[6]
Duan, F., Cui, L., Bai, Y., Li, X., Yan, J., & Liu, X. (2017). Comparison of Efficacy and Complications of Endoscopic and Percutaneous Biliary Drainage in Malignant Obstructive Jaundice: Has Systematic Review and Meta-Analysis. Cancer Imaging, 17, Article No. 27. https://doi.org/10.1186/s40644-017-0129-1
[7]
Guyatt, G. H., Oxman, A. D., Vist, G. E. et al. (2008). GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations. BMJ, 336, 924-926. https://doi.org/10.1136/bmj.39489.470347.AD
[8]
Hyodo, T., Murakami, T., Imai, Y. et al. (2013). Hypovascular Nodules in Patients with Chronic Liver Disease: Risk Factors for Development of Hypervascular Hepatocellular Carcinoma. Radiology, 266, 480-490. https://doi.org/10.1148/radiol.12112677
[9]
Joo, I., Lee, J. M., Lee, D. H., Jeon, J. H., Han, J. K., & Choi, B. I. (2015). Noninvasive Diagnosis of Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI: Can Hypointensity on the Hepatobiliary Phase Be Used as an Alternative to Washout? European Radiology, 25, 2859-2868. https://doi.org/10.1007/s00330-015-3686-3
[10]
Kang, Y., Lee, J. M., Kim, S. H., Han, J. K., & Choi, B. I. (2012). Intrahepatic Mass-Forming Cholangiocarcinoma: Enhancement Patterns on Gadoxetic Acid-Enhanced MR Images. Radiology, 264, 751-760. https://doi.org/10.1148/radiol.12112308
[11]
Park, M. S, Kim, S., Patel, J. et al. (2012). Hepatocellular Carcinoma: Detection with Diffusionweighted versus Contrast-Enhanced Magnetic Resonance Imaging in Pretransplant Patients. Hepatology, 56, 140-148. https://doi.org/10.1002/hep.25681
[12]
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S. et al. (2023) AASLD Practice Guidance on the Clinicalassessment and Management of Non-Alcoholic Fatty Liver Disease. Hepatology, 77, 1797-1835. https://doi.org/10.1097/HEP.0000000000000323
[13]
Tanabe, M., Kanki, A., Wolfson, T., Costa, E. A., Mamidipalli, A., Ferreira, M. P., Santillan, C., Middleton, M. S., Gamst, A. C., Kono, Y., Kuo, A., & Sirlin, C. B. (2016). Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging. Radiology, 281, 129-139. https://doi.org/10.1148/radiol.2016152173
[14]
Tang, A., Valasek, M. A., & Sirlin, C. B. (2015). Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know. Advances In Anatomic Pathology, 22, 314-322. https://doi.org/10.1097/PAP.0000000000000089
[15]
Valls, C. (2006). Bare Jaundice: Role of the Radiologist in Diagnosis and Therapeutic Management. Journal de Radiologie, 87, 460-476. https://doi.org/10.1016/S0221-0363(06)74027-6
[16]
Zhang, Y. D., Zhu, F. P., Xu, X. et al. (2016). Classifying CT/MR Findings in Patients with Suspicion of Hepatocellular Carcinoma: Comparison of Liver Imaging Reporting and Data System and Criteria-Free Likert Scale Reporting Models. Journal of Magnetic Resonance Imaging, 43, 373-383. https://doi.org/10.1002/jmri.24987
